vimarsana.com

Latest Breaking News On - Jackie fairley - Page 6 : vimarsana.com

SPL7013 in VIRALEZE virucidal against influenza A and B (ASX Announcement)

The broad-spectrum antiviral agent in VIRALEZE™ nasal spray, SPL7013, achieved 95% and 99

United kingdomRepublic ofJackie fairleyScripps research instituteOpitalia groupMiddle eastSwine fluAvian fluInfectious influenzaGraphpad prismAntiviral nasalGlobal healthMedical specialtiesFlu seasonInfluenza pandemic

Company | SPL | Starpharma Holdings News, Analysis, Announcements and Results

The latest Starpharma Holdings news, articles, data and analysis from Brisbane Times

United kingdomJackie fairleyEmma koehn

Active agent in Australian-developed nasal spray >99 5% active against the Omicron SARS-CoV-2 variant

The antiviral agent in VIRALEZE™ antiviral nasal spray, SPL7013, achieved >99.5% reduction of virus infectivity (the maximal possible reduction) against.

Republic ofSaudi arabiaUnited statesNew zealandJackie fairleyPhilippe gallayScripps research instituteScripps researchProfessor philippe gallayOpportunistic infectionsAbstracts from

Markets Live, Monday February 21, 2022

The latest ASX live news from the Market Live team, including live ASX price, live ASX company news, and more.

Republic ofSaudi arabiaNew zealandUnited kingdomJackie fairleyJustin mcmanus

Starpharma (ASX:SPL) pens distribution deal in Saudi Arabia

Starpharma (ASX:SPL) has signed a distribution agreement for its antiviral nasal spray across nine new countries.

New zealandRepublic ofSaudi arabiaUnited arab emiratesJackie fairleyEtqan nazahah

vimarsana © 2020. All Rights Reserved.